Assuntos
Encefalopatias/fisiopatologia , Competência Clínica , Neurologia/ética , Adulto , Idoso , Anticoagulantes/efeitos adversos , Anticoagulantes/uso terapêutico , Encefalopatias/diagnóstico , Encefalopatias/psicologia , Cefaleia Histamínica/diagnóstico , Cefaleia Histamínica/terapia , Diagnóstico Diferencial , Feminino , Arterite de Células Gigantes/diagnóstico , Arterite de Células Gigantes/psicologia , Arterite de Células Gigantes/terapia , Cefaleia/diagnóstico , Cefaleia/etiologia , Cefaleia/terapia , Heparina/efeitos adversos , Heparina/uso terapêutico , Síndrome de Horner/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Neurologia/normas , Síndrome SUNCT/diagnóstico , Síndrome SUNCT/terapia , Trombose do Seio Sagital/induzido quimicamente , Trombose do Seio Sagital/fisiopatologia , Trombose do Seio Sagital/psicologia , Hemorragia Subaracnóidea/complicações , Hemorragia Subaracnóidea/fisiopatologia , Hemorragia Subaracnóidea/psicologia , Tendinopatia/diagnóstico , Tendinopatia/terapia , Dissecação da Artéria Vertebral/diagnóstico , Dissecação da Artéria Vertebral/psicologia , Dissecação da Artéria Vertebral/terapia , Adulto JovemRESUMO
BACKGROUND AND PURPOSE: Little data exists about longterm outcome, quality of life (QOL) and its predictors after spontaneous cervical artery dissections (sCAD). METHODS: Clinical and radiological data of 114 patients with sCAD were collected prospectively. Six patients died within 3 months, the remaining 108 were contacted after a mean of 1498 days (range: 379-3455), 99 survivors (92 %) replied. QOL, assessed with the stroke-specific QOL scale (SSQOL), and functional abilities, measured with modified Rankin Scale (mRS) were compared, and predictors of QOL were analyzed. Subgroup analyses were performed for patients with ischemic stroke, those with isolated local symptoms or transient ischemic symptoms and those without significant disabilities (mRS 0-1) at follow-up. RESULTS: Seventy-one of 99 patients (72 %) had no significant disability, but only 53 (54 %) reported a good QOL (SS-QOL > or = 4). Compared to the self-rated premorbid QOL of all patients, SS-QOL was impaired after sCAD (p < 0.001); impairment of QOL was observed in patients with ischemic stroke (p < 0.001), in patients with isolated local or transient ischemic symptoms (p < 0.038) and those without significant disabilities at follow-up (p = 0.013). Nevertheless, low mRS was associated with better overall QOL (Kendall's tau > 0.5). High National Institute of Health Stroke Scale score on admission and higher age were independent predictors of impaired QOL (p < 0.05). CONCLUSION: QOL is impaired in almost half of long-term survivors after sCAD, even in patients with local or transient symptoms or without functional disability. Impairment of QOL is a surprisingly frequent long-term sequela after sCAD and deserves attention as an outcome measure in these patients.